Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB08801ApprovedInvestigationalSmall molecule
Dimetindene is a 1st generation selective H1 antagonist used topically as an antipruritic and orally to treat allergies.
- Mechanism
- Curator reviewed
Dimethindene is a selective histamine H1 antagonist and binds to the histamine H1 receptor. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine.
- Primary indication
- Indicated as symptomatic treatment of allergic reactions: urticaria, allergies of the upper respiratory tract such as hey fever and perennial rhinitis, food and drug allergies; pruritus of various origins, except pruritus due to cholestasis; insect...Curator reviewed · 12 structured indications
- Formula / weight
- C20H24N2 · 292.418 g/mol (avg)
- Also known as
- Dimethindene
Resolves to
Clinical / RWD
Structure
InChIKey
MVMQESMQSYOVGV-UHFFFAOYSA-NSMILESCC(C1=C(CCN(C)C)CC2=CC=CC=C12)C1=CC=CC=N1Targets
What you can answer from here — as of September 23, 2026
2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Dimetindene, and which of those have an active Phase 3 trial?